Financing

Other, net

Medtronic Other, net increased by 125.0% to $70.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 566.7%, from -$15.00M to $70.00M. Over 3 years (FY 2021 to FY 2025), Other, net shows an upward trend with a -12.3% CAGR.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026Aug 26, 2025

How to read this metric

Fluctuations are often non-recurring; significant changes should be analyzed via footnotes to determine if they represent structural shifts in financing strategy.

Detailed definition

This metric aggregates miscellaneous cash flows related to financing activities that do not fall into primary categories...

Peer comparison

Standard line item in cash flow statements; varies significantly by company based on the complexity of their capital structure.

Metric ID: financing_proceeds_from_payments_for_other_financing_activities

Historical Data

16 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$164.00M-$4.00M$447.00M-$495.00M$215.00M$273.00M-$120.00M-$429.00M-$133.00M-$8.00M-$56.00M-$15.00M$80.00M$31.00M-$280.00M$70.00M
QoQ Change+97.6%>999%-210.7%+143.4%+27.0%-144.0%-257.5%+69.0%+94.0%-600.0%+73.2%+633.3%-61.3%<-999%+125.0%
YoY Change+231.1%>999%-126.8%+13.3%-161.9%-102.9%+53.3%-87.5%+242.9%+566.7%
Range-$495.00M$447.00M
CAGR-20.3%
Avg YoY Growth+755.3%
Median YoY Growth+33.3%

Frequently Asked Questions

What is Medtronic's other, net?
Medtronic (MDT) reported other, net of $70.00M in Q2 2025.
How has Medtronic's other, net changed year-over-year?
Medtronic's other, net increased by 566.7% year-over-year, from -$15.00M to $70.00M.
What is the long-term trend for Medtronic's other, net?
Over 3 years (2021 to 2025), Medtronic's other, net has grown at a -12.3% compound annual growth rate (CAGR), from -$273.00M to -$184.00M.
What does other, net mean?
Net cash flows from secondary or miscellaneous financing activities.